Arcalyst
Active substance: rilonacept
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · RILONACEPT 160 mg/2mL
United StatesActive
Marketing holder: Kiniksa Pharmaceuticals (UK), Ltd.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- RILONACEPT · 160 mg/2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 2 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-d116-7e82-a3bf-b68dd1232dbd;count=1 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73604-914
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 73604-914 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73604-914 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73604-914 · Verified 2026-10-09 · open in source